Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of cancer and other target diseases worldwide
3.2.1.2 Growing adoption of biomarkers
3.2.1.3 Increasing number of clinical trials pertaining to cancer drugs
3.2.1.4 Increasing technological advancements of pathology equipment
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of equipment
3.2.2.2 Availability of refurbished anatomic pathology systems
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Future market trends
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product and Service, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Instruments
5.2.1 Microtomes
5.2.2 Cell processors
5.2.3 Tissue processing systems
5.2.4 Slide staining systems
5.2.5 Embedding systems
5.2.6 Coverslippers
5.2.7 Other instruments
5.3 Consumables
5.3.1 Antibodies
5.3.1.1 Primary antibodies
5.3.1.2 Secondary antibodies
5.3.2 Kits and reagents
5.3.2.1 Stains and solvents
5.3.2.2 Fixatives
5.3.2.3 Other kits and reagents
5.3.3 Probes
5.3.4 Other consumables
5.4 Services
5.4.1 Histopathology
5.4.2 Cytopathology
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Diseases diagnostics
6.2.1 Cancer
6.2.1.1 Breast cancer
6.2.1.2 Gastrointestinal cancer
6.2.1.3 Lung cancer
6.2.1.4 Prostate cancer
6.2.1.5 Other cancer types
6.2.2 Other diseases
6.3 Research
Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Diagnostic centers
7.4 Other end users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 Supply-side
9.1.1 Agilent Technologies
9.1.2 Becton, Dickinson and Company
9.1.3 Cardinal Health
9.1.4 Danaher Corporation
9.1.5 F. Hoffmann-La Roche
9.1.6 Merck
9.1.7 Thermo Fisher Scientific
9.2 Demand-side (Laboratories)
9.2.1 Ampath Laboratories
9.2.2 Al Borg Medical Laboratories
9.2.3 Biolab
9.2.4 Eurofins Scientific
9.2.5 Laboratoires Réunis
9.2.6 Lifebrain Group
9.2.7 Lancet Laboratories
9.2.8 Medsol Diagnostics
9.2.9 Synlab Group
9.2.10 Unilabs
